PALI MOMI MEDICAL CENTER
1. Target Overview & Investment Thesis
PALI MOMI MEDICAL CENTER is a 118-bed suburban community hospital in HONOLULU, HI with $303.6M in net patient revenue and a 6.6% operating margin. The hospital serves a payer mix of 27.9% Medicare, 0.2% Medicaid, and 72.0% commercial.
Thesis: Turnaround. Our ML models identify $22.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.6% to 14.0% (+736bps).
| Net Revenue HCRIS | $303.6M |
| Current EBITDA COMPUTED | $20.1M |
| Operating Margin COMPUTED | 6.6% |
| Occupancy HCRIS | 82.2% |
| Revenue / Bed COMPUTED | $2.6M |
| Net-to-Gross HCRIS | 35.2% |
| Distress Probability ML | 38.5% |
2. Market Context & Competitive Position
HI has 26 Medicare-certified hospitals with a median operating margin of -14.7%. The target's margin of 6.6% places it above the state median. Among 9 size-comparable peers (59-236 beds), the median margin is -15.6%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (59-236), prioritizing same-state peers. 9 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PALI MOMI MEDICAL CENTER (Target) | HI | 118 | $303.6M | 6.6% |
| STRAUB CLINIC & HOSPITAL | HI | 159 | $537.5M | 4.1% |
| MAUI MEMORIAL MEDICAL CENTER | HI | 219 | $335.5M | -3.5% |
| HILO MEDICAL CENTER | HI | 194 | $263.6M | -19.5% |
| ADVENTIST HEALTH CASTLE | HI | 160 | $187.9M | -13.9% |
| WILCOX MEMORIAL HOSPTIAL | HI | 72 | $152.0M | 2.6% |
| KUAKINI MEDICAL CENTER | HI | 170 | $144.7M | -16.1% |
| KONA COMMUNITY HOSPITAL | HI | 83 | $105.2M | -37.0% |
| REHABILITATION HOSPITAL OF THE | HI | 82 | $41.9M | -15.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $22.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $6.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $6.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $194K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $20.1M |
| + RCM Uplift | +$22.3M |
| Pro Forma EBITDA | $42.5M |
| Current Margin | 6.6% |
| Pro Forma Margin | 14.0% |
| WC Released (1x) | $11.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $30.9M | $356.1M | 11.51x | 63.0% |
| Base (11x exit) | 10.0x | 11.0x | $30.9M | $401.8M | 12.99x | 67.0% |
| Bull Case | 9.0x | 11.0x | $27.8M | $485.6M | 17.44x | 77.1% |
| Bull (12x exit) | 9.0x | 12.0x | $27.8M | $537.9M | 19.32x | 80.8% |
| Bear Case | 11.0x | 10.0x | $34.0M | $234.3M | 6.89x | 47.1% |
| Bear (11x exit) | 11.0x | 11.0x | $34.0M | $268.8M | 7.90x | 51.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 9 hospitals with 59-236 beds
- Same-state prioritization (n=10)
- Comp margins: P25=-19.5% / P50=-15.6% / P75=-3.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.